
Japan · Research startup
We are an enterprise specialized in research and development of new small molecule drugs.
Funding reportedLast round: Series A
We are an enterprise specialized in research and development of new small molecule drugs.
Our unique medicinal chemistry platform HiSAP® solves the problems of innovative drugs, such as weak therapeutic effect, strong side effects, and low bioavailability.
Funding, as reported
What they build
Known for
health caremedical innovationhealthcare analyticsbiotechnology researchpharmaceutical pipelinehealthcarepharmaceutical developmenthealth productsmedical researchpharmaceuticalshealth techhealth innovation pipelinenew drug discoverydrug pipelinehospital & health caremedical advancements
Built with from their website
Locomotive ScrollGoogle AnalyticsMicrosoft Email ProvidersGoogle Tag ManagerLenisGoogle Hosted LibrariescdnjsGoogle Font APIGoogle Analytics 4Microsoft Exchange
NginxjQueryMicrosoft 365ProgressBar.jsFont AwesomeMicrosoft Exchange OnlineOutlookCloudFlare
Add your raise, your deck and your story, and put Alchemedicine, Inc. in front of investors. Or tell us what we have wrong.